Similar Search Results

Incorporating innovation subsidies in the CDM framework : empirical evidence from Belgium

Czarnitzki, Dirk; Delanote, Julie - 2016 - This version: May 2016

Persistent link: https://www.econbiz.de/10011527417

The Italian Startup Act : empirical evidence of policy effects

Biancalani, Francesco; Czarnitzki, Dirk; Riccaboni, Massimo - 2020

Persistent link: https://www.econbiz.de/10012242920

What drives business research and development (R&D) intensity across Organisation for Economic Co-operation and Development (OECD) countries?

Falk, Martin - In: Applied economics 38 (2006) 5, pp. 533-547

Persistent link: https://www.econbiz.de/10003309111

How effective are level-based R&D tax credits? : evidence from the Netherlands

Lokshin, Boris; Mohnen, Pierre A. - In: Applied economics 44 (2012) 10/12, pp. 1527-1538

Persistent link: https://www.econbiz.de/10009525248

(International) R&D collaboration and SMEs : the effectiveness of targeted public R&D support schemes

Hottenrott, Hanna; Lopes Bento, Cindy - 2012

Persistent link: https://www.econbiz.de/10009731609

Estimating the local average treatment effect of R&D subsidies in a pan-European program

Hünermund, Paul; Czarnitzki, Dirk - 2016

Persistent link: https://www.econbiz.de/10011527408

Radical or incremental : where does R&D policy hit?

Beck, Mathias; Lopes Bento, Cindy; Schenker-Wicki, Andrea - 2014

Persistent link: https://www.econbiz.de/10010419784

Inducing private clean innovations

Veugelers, Reinhilde - 2012

Persistent link: https://www.econbiz.de/10009678489

Value for Money? New Microeconometric Evidence on Public R&D Grants in Flanders

Czarnitzki, Dirk - 2012

A significant amount of money is spent on programs to stimulate innovative activities. In this paper, we review the effects of a specific government-sponsored commercial R&D program from various angles. We start by evaluating whether we find positive effects of subsidies on R&D investment and...

Persistent link: https://www.econbiz.de/10013105171

Public subsidies for R&D and public sector pharmaceutical innovation

Kourouklis, Dimitrios - In: Applied economics 53 (2021) 32, pp. 3759-3777

Persistent link: https://www.econbiz.de/10012589537